Participation in a Single-Blinded Pediatric Therapeutic Strategy Study for Juvenile Idiopathic Arthritis: Are Parents and Patient-Participants in Equipoise?

BMC Medical Ethics - United Kingdom
doi 10.1186/s12910-018-0336-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Juvenile Idiopathic Arthritis – Diagnostic and Therapeutic Procedures

Farmacja Polska
2019English

Mixed Cryoglobulinemia in a Patient With Juvenile Idiopathic Arthritis

Case Reports in Rheumatology
2019English

Participation in School and Physical Education in Juvenile Idiopathic Arthritis in a Nordic Long-Term Cohort Study

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2019English

Tocilizumab for Juvenile Idiopathic Arthritis: A Single-Center Case Series

Sao Paulo Medical Journal
Medicine
2019English

Extension Study of Participants From the Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2014English

Efficacy of Adalimumab in a Patient With Juvenile Idiopathic Arthritis and Uveitis

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2012English

Patient Factors Associated With Waiting Time to Pediatric Rheumatologist Consultation for Patients With Juvenile Idiopathic Arthritis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2020English

Atherosclerosis in Juvenile Idiopathic Arthritis

Mediators of Inflammation
ImmunologyCell Biology
2012English

Juvenile Idiopathic Arthritis

The Lancet
Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy